{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-25-000194","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.543486+00:00","generated_at":"2026-05-21T11:52:46.193744+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Vertex shareholders elect all 11 directors, reject golden parachute proposal at 2025 annual meeting","bullets":["All 11 director nominees elected with majority support; Bruce Sachs received lowest 'for' votes at 211.6M.","Ratification of Ernst & Young as auditor for FY2025 passed with 229.4M votes for, 6.9M against.","Advisory vote on 2024 named executive officer compensation approved: 208.9M for, 17.0M against.","Shareholder proposal on excessive golden parachutes rejected: 84.1M for, 141.6M against."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-25-000194","json":"https://secwatch.observer/filing/0000875320-25-000194.json","markdown":"https://secwatch.observer/filing/0000875320-25-000194.md","text":"https://secwatch.observer/filing/0000875320-25-000194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/0000875320-25-000194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000194/vrtx-20250514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T11:52:46.193744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}